323 related articles for article (PubMed ID: 2941082)
1. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
2. Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodgkin's lymphomas.
Foon KA
Curr Probl Cancer; 1989; 13(2):57-128. PubMed ID: 2659257
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the immunologic classification of leukemia.
Foon KA; Gale RP; Todd RF
Semin Hematol; 1986 Oct; 23(4):257-83. PubMed ID: 3095928
[TBL] [Abstract][Full Text] [Related]
4. Immunologic classification of lymphoma and lymphoid leukemia.
Foon KA; Gale RP
Blood Rev; 1987 Jun; 1(2):77-88. PubMed ID: 3332096
[TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
6. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
7. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
Kikuchi K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
[TBL] [Abstract][Full Text] [Related]
9. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of monoclonal antibodies LAU-A1 and anti-Y 29/55 in T and B cell malignancies of children: correlation with immunological markers and clinical data.
Hirt A; Carrel S; Forster HK; Baumgartner C; Imbach P; Signer E; Wagner HP
Acta Haematol; 1986; 76(1):9-15. PubMed ID: 3098032
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
12. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
Liendo C; Danieu L; Al-Katib A; Koziner B
Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
[TBL] [Abstract][Full Text] [Related]
14. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
[No Abstract] [Full Text] [Related]
15. Expression of normal myeloid-associated antigens by acute leukemia cells.
Dinndorf PA; Andrews RG; Benjamin D; Ridgway D; Wolff L; Bernstein ID
Blood; 1986 Apr; 67(4):1048-53. PubMed ID: 2937468
[TBL] [Abstract][Full Text] [Related]
16. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
[TBL] [Abstract][Full Text] [Related]
17. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
18. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
19. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
Swerdlow SH; Wright SA
Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
